2008 COMPENSATION INFORMATION FOR NAMED EXECUTIVE OFFICERS
Exhibit 10.43
2008 COMPENSATION INFORMATION FOR NAMED EXECUTIVE OFFICERS
The table below provides information regarding the 2008 annual base salary for each named executive officer of Kosan Biosciences Incorporated (the “Company”). Also listed in the table below are the target cash bonus amounts for each of the Company’s named executive officer under the Company’s 2008 Executive Officer Cash Bonus Plan.
| Named Executive Officer | 2008 Annual Base Salary | 2008 Target Cash Bonus | |||
| Robert G. Johnson, Jr., M.D., Ph.D. President and Chief Executive Officer | 430,000 | 45 | % | ||
| Gary S. Titus Senior Vice President and Chief Financial Officer | 322,000 | 35 | % | ||
| Peter J. Licari, Ph.D. Senior Vice President, Manufacturing and Operations | 270,000 | 35 | % | ||
| Pieter B.M.W.M. Timmermans, Ph.D. Senior Vice President, Drug Discovery and Preclinical Research | 270,000 | 35 | % |
| (1) | Each target cash bonus amount is expressed as a percentage of the respective named executive officer’s 2008 annual base salary. |
| (2) | Target cash bonus amounts are based on 100% achievement of corporate objectives and, if applicable, individual performance objectives. Actual bonus payments (if any) may represent a higher or lower percentage of the named executive officer’s 2008 annual base salary, depending on the extent to which actual performance meets, exceeds or falls short of the specified corporate objectives and applicable individual performance objectives, as determined by the Compensation Committee in its discretion. |
